Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR)
ARWR Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-33.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
24.20%
ARWR Stock Analysis
ARWR
PE Ratio:
ARWR
PEG Ratio:
Not Available
ARWR
Forward EPS Growth (12 month):
0.00%
ARWR
PS Ratio:
16.4
ARWR
PSG Ratio:
-0.6
ARWR
Forward Revenue Growth (12 month):
-26.10%
ARWR Articles
No data was found